SE9102462D0 - New isosteric peptides - Google Patents

New isosteric peptides

Info

Publication number
SE9102462D0
SE9102462D0 SE9102462A SE9102462A SE9102462D0 SE 9102462 D0 SE9102462 D0 SE 9102462D0 SE 9102462 A SE9102462 A SE 9102462A SE 9102462 A SE9102462 A SE 9102462A SE 9102462 D0 SE9102462 D0 SE 9102462D0
Authority
SE
Sweden
Prior art keywords
phenyl
group
methyl
carbon atoms
straight
Prior art date
Application number
SE9102462A
Other languages
English (en)
Swedish (sv)
Inventor
B Atrash
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9102462A priority Critical patent/SE9102462D0/xx
Publication of SE9102462D0 publication Critical patent/SE9102462D0/xx
Priority to NZ243675A priority patent/NZ243675A/xx
Priority to ZA925737A priority patent/ZA925737B/xx
Priority to IL102840A priority patent/IL102840A0/xx
Priority to APAP/P/1992/000418A priority patent/AP313A/en
Priority to MX9204767A priority patent/MX9204767A/es
Priority to DZ920109A priority patent/DZ1613A1/fr
Priority to TW081106578A priority patent/TW221816B/zh
Priority to DE69232394T priority patent/DE69232394T2/de
Priority to SK233-94A priority patent/SK23394A3/sk
Priority to HU9400589A priority patent/HUT66060A/hu
Priority to EP92918722A priority patent/EP0605462B1/en
Priority to AU24990/92A priority patent/AU2499092A/en
Priority to CA002116527A priority patent/CA2116527A1/en
Priority to JP50513493A priority patent/JP3353297B2/ja
Priority to CS94380A priority patent/CZ38094A3/cs
Priority to AT92918722T priority patent/ATE212643T1/de
Priority to EP92850201A priority patent/EP0530167A1/en
Priority to PCT/SE1992/000584 priority patent/WO1993005069A1/en
Priority to MA22922A priority patent/MA22632A1/fr
Priority to IS3906A priority patent/IS3906A/is
Priority to SI19929200193A priority patent/SI9200193A/sl
Priority to TNTNSN92076A priority patent/TNSN92076A1/fr
Priority to CN92109600A priority patent/CN1069736A/zh
Priority to NO940669A priority patent/NO940669L/no
Priority to BG98583A priority patent/BG98583A/bg
Priority to FI940945A priority patent/FI940945A0/fi
Priority to US08/288,657 priority patent/US5424291A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9102462A 1991-08-28 1991-08-28 New isosteric peptides SE9102462D0 (sv)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE9102462A SE9102462D0 (sv) 1991-08-28 1991-08-28 New isosteric peptides
NZ243675A NZ243675A (en) 1991-08-28 1992-07-22 Isosteric peptide inhibitor of thrombin and pharmaceutical compositions
ZA925737A ZA925737B (en) 1991-08-28 1992-07-30 New isosteric peptides.
IL102840A IL102840A0 (en) 1991-08-28 1992-08-17 New isosteric peptides
APAP/P/1992/000418A AP313A (en) 1991-08-28 1992-08-17 New isosteric peptides.
MX9204767A MX9204767A (es) 1991-08-28 1992-08-18 Nuevos peptidos isostericos, proceso para su preparacion y composicion farmaceutica que los contiene
DZ920109A DZ1613A1 (fr) 1991-08-28 1992-08-18 Nouveaux peptides isosteres.
TW081106578A TW221816B (bg) 1991-08-28 1992-08-19
PCT/SE1992/000584 WO1993005069A1 (en) 1991-08-28 1992-08-25 New isosteric peptides
AU24990/92A AU2499092A (en) 1991-08-28 1992-08-25 New isosteric peptides
EP92850201A EP0530167A1 (en) 1991-08-28 1992-08-25 New isosteric peptides
HU9400589A HUT66060A (en) 1991-08-28 1992-08-25 Process for producing peptide derivatives of thrombin-inhibiting activity
EP92918722A EP0605462B1 (en) 1991-08-28 1992-08-25 New isosteric peptides
DE69232394T DE69232394T2 (de) 1991-08-28 1992-08-25 Neue isosterische peptide
CA002116527A CA2116527A1 (en) 1991-08-28 1992-08-25 New isosteric peptides
JP50513493A JP3353297B2 (ja) 1991-08-28 1992-08-25 新規なアイソステリックペプチド
CS94380A CZ38094A3 (en) 1991-08-28 1992-08-25 Novel isosteric peptides
AT92918722T ATE212643T1 (de) 1991-08-28 1992-08-25 Neue isosterische peptide
SK233-94A SK23394A3 (en) 1991-08-28 1992-08-25 New isosteric peptides
MA22922A MA22632A1 (fr) 1991-08-28 1992-08-26 Nouveaux peptides isosteres .
IS3906A IS3906A (is) 1991-08-28 1992-08-27 Hliðstæð aðferð við framleiðslu nýrra ísósterískra peptíða
SI19929200193A SI9200193A (en) 1991-08-28 1992-08-27 New isosteric peptides
TNTNSN92076A TNSN92076A1 (fr) 1991-08-28 1992-08-27 Nouveaux peptides isosteres
CN92109600A CN1069736A (zh) 1991-08-28 1992-08-28 新的同配多肽
NO940669A NO940669L (no) 1991-08-28 1994-02-25 Nye isosteriske peptider
BG98583A BG98583A (bg) 1991-08-28 1994-02-25 Изостерни пептиди
FI940945A FI940945A0 (fi) 1991-08-28 1994-02-28 Uusia isosteerisiä peptidejä
US08/288,657 US5424291A (en) 1991-08-28 1994-08-10 Isosteric peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9102462A SE9102462D0 (sv) 1991-08-28 1991-08-28 New isosteric peptides

Publications (1)

Publication Number Publication Date
SE9102462D0 true SE9102462D0 (sv) 1991-08-28

Family

ID=20383557

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9102462A SE9102462D0 (sv) 1991-08-28 1991-08-28 New isosteric peptides

Country Status (27)

Country Link
US (1) US5424291A (bg)
EP (2) EP0530167A1 (bg)
JP (1) JP3353297B2 (bg)
CN (1) CN1069736A (bg)
AP (1) AP313A (bg)
AT (1) ATE212643T1 (bg)
AU (1) AU2499092A (bg)
BG (1) BG98583A (bg)
CA (1) CA2116527A1 (bg)
CZ (1) CZ38094A3 (bg)
DE (1) DE69232394T2 (bg)
DZ (1) DZ1613A1 (bg)
FI (1) FI940945A0 (bg)
HU (1) HUT66060A (bg)
IL (1) IL102840A0 (bg)
IS (1) IS3906A (bg)
MA (1) MA22632A1 (bg)
MX (1) MX9204767A (bg)
NO (1) NO940669L (bg)
NZ (1) NZ243675A (bg)
SE (1) SE9102462D0 (bg)
SI (1) SI9200193A (bg)
SK (1) SK23394A3 (bg)
TN (1) TNSN92076A1 (bg)
TW (1) TW221816B (bg)
WO (1) WO1993005069A1 (bg)
ZA (1) ZA925737B (bg)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ333492A3 (en) * 1991-11-12 1993-09-15 Lilly Co Eli Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
JPH06329627A (ja) * 1993-05-03 1994-11-29 Bristol Myers Squibb Co グアニジニル−またはアミジニル−置換ヘテロ環トロンビンインヒビター
US6984627B1 (en) 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5780631A (en) * 1993-06-03 1998-07-14 Astra Aktiebolag Starting materials in the synthesis of thrombin and kininogenase inhibitors
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
DE4421052A1 (de) 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
MX9706069A (es) * 1995-02-17 1997-10-31 Basf Ag Nuevos inhibidores de la trombina.
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AR005245A1 (es) * 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
JP2002501081A (ja) 1998-01-26 2002-01-15 ビーエーエスエフ アクチェンゲゼルシャフト トロンビンインヒビター
IL139162A0 (en) 1998-04-24 2001-11-25 Dimensional Pharm Inc Amidinohydrazone, alkoxyguanidine and aminoguanidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9804313D0 (sv) 1998-12-14 1998-12-14 Astra Ab New compounds
TR200102037T2 (tr) 1999-01-13 2001-10-22 Astrazeneca Ab Yeni amidinobenzilamin türevleri ve trombin engelleyiciler olarak kullanılmaları.
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
AU1226001A (en) * 1999-11-09 2001-06-06 Alcon Universal Limited Phospholipids of hydroxyeicosatetraenoic acid-like derivatives
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
ES2819218T3 (es) 2014-10-06 2021-04-15 Cortexyme Inc Inhibidores de lisina gingipaína
EP3374352A4 (en) 2015-11-09 2019-10-02 Cortexyme, Inc. GINGIPAINE ARGININE INHIBITORS
EP3426674A4 (en) 2016-03-09 2019-08-14 Blade Therapeutics, Inc. CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU2017292646A1 (en) 2016-07-05 2019-02-07 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
WO2018053353A1 (en) 2016-09-16 2018-03-22 Cortexyme, Inc. Ketone inhibitors of lysine gingipain
SG10201912574WA (en) 2016-09-28 2020-02-27 Blade Therapeutics Inc Calpain modulators and therapeutic uses thereof
RU2020130022A (ru) * 2018-03-28 2022-05-04 Блэйд Терапьютикс, Инк. Модуляторы кальпаина и их терапевтическое применение

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318904A (en) * 1980-04-25 1982-03-09 Research Corporation Peptide affinity labels for thrombin and other trypsin-like proteases
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
DE3505555A1 (de) * 1985-02-18 1986-09-11 Behringwerke Ag, 3550 Marburg Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents

Also Published As

Publication number Publication date
NO940669L (no) 1994-04-19
AU2499092A (en) 1993-04-05
DZ1613A1 (fr) 2002-02-17
MA22632A1 (fr) 1993-04-01
TW221816B (bg) 1994-03-21
ZA925737B (en) 1993-03-01
AP313A (en) 1994-02-10
EP0605462B1 (en) 2002-01-30
FI940945A (fi) 1994-02-28
MX9204767A (es) 1993-05-01
JP3353297B2 (ja) 2002-12-03
WO1993005069A1 (en) 1993-03-18
IS3906A (is) 1993-03-01
AP9200418A0 (en) 1992-10-31
CA2116527A1 (en) 1993-03-18
FI940945A0 (fi) 1994-02-28
HUT66060A (en) 1994-09-28
DE69232394T2 (de) 2002-08-22
ATE212643T1 (de) 2002-02-15
NO940669D0 (no) 1994-02-25
BG98583A (bg) 1994-09-30
US5424291A (en) 1995-06-13
DE69232394D1 (de) 2002-03-14
CZ38094A3 (en) 1994-08-17
JPH06510059A (ja) 1994-11-10
SI9200193A (en) 1993-06-30
NZ243675A (en) 1994-06-27
EP0530167A1 (en) 1993-03-03
IL102840A0 (en) 1993-01-31
EP0605462A1 (en) 1994-07-13
SK23394A3 (en) 1994-08-10
TNSN92076A1 (fr) 1993-06-08
HU9400589D0 (en) 1994-05-30
CN1069736A (zh) 1993-03-10

Similar Documents

Publication Publication Date Title
SE9102462D0 (sv) New isosteric peptides
DE69214632D1 (de) 7-phenylethynyl-substituierte chromane und thiochromane mit retinoid-ähnlicher biologischer aktivität
KR970010741A (ko) 히드록삼산 유도체
BRPI0211844B8 (pt) composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
FI882176A0 (fi) Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita
EP0368640A3 (en) Heterocyclic compounds
ATE448194T1 (de) Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts
GB9202791D0 (en) Compounds
EP0353955A3 (en) Novel compounds
DE3888340T2 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
RU94044433A (ru) Смеси из оптически активных простых циклогексеноноксимовых эфиров, способ их получения и промежуточные продукты для их получения и их применение в качестве гербицидов
ATE142627T1 (de) Methode zur verbesserung des schlafes
HUT54277A (en) Fungicidal compositions comprising 3-(methoxyimino)-propionic acid esters as active ingredient and process for producing the active ingredients
JO1734B1 (en) New peptide compounds that are symmetric with electronic distribution of molecules
MY113529A (en) New derivatives of imidazole n- benzyldioxole,processes for their preparation, their use as medicaments and pharmaceutical compositions containing them
NO170974C (no) Analogifremgangsmaate for fremstilling av terapeutisk brukbare ((((3-pyridinyl)metylen)amino)oksy)alkansyrer og estere derav samt mellomprodukt for anvendelse ved fremgangsmaaten
GB1334693A (en) Acenaphthene derivatives
EP0201349A3 (en) Tetrazole derivatives
YU82792A (sh) Novi izosterni peptidi
GR3018329T3 (en) Novel benzopyran derivatives and processes for the preparation thereof.
TH13499EX (th) ไอโซสเทอริคเพพไทด์ชนิดใหม่
EP0492483A3 (en) Compositions containing 1 or more n-(phenyl-(thioxomethyl))-morpholine derivative(s) and the use of these compounds
TH13499A (th) ไอโซสเทอริคเพพไทด์ชนิดใหม่
DE69614508D1 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
IL100599A (en) Substituted alkenoic acid and its derivatives process and inetermediates for their preparation and pharmaceutical compositions containing them